The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study
Conditions: Bacterial Keratitis; Fungal Keratitis; Mixed Bacterial and Fungal Keratitis; Microbial Keratitis Interventions: Drug: Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution; Drug: Ceftazidime 5% + vancomycin 5%; Drug: Gentamicin 1.4% + vancomycin 5%; Drug: Natamycin 5% Oph Susp; Drug: Voriconazole 1%; Drug: Natamycin 5% + voriconazole 1%; Drug: Natamycin 5%+ ceftazidime 5% + vancomycin 5%; Drug: Voriconazole 1% + ceftazidime 5% + vancomycin 5% Sponsor: Alexandria University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2022 Category: Research Source Type: clinical trials
A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants
Condition: Healthy Interventions: Drug: Selpercatinib; Drug: Moxifloxacin; Drug: Placebo Sponsors: Eli Lilly and Company; Loxo Oncology, Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2022 Category: Research Source Type: clinical trials